Delivery Order SPE2DB22D1202-SPE2DB25FUPZ5

Award Date 1/17/25
Potential Completion Date 1/21/25
Potential Value $4K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a $7,069.86 firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corporation's Corporate Office division. The contract is for the supply of HUMALOG 100 UNIT/ML KWIKPEN 3ML, a prescription insulin medication. The order has an ultimate completion date of August 21, 2024. AmerisourceBergen, one of the largest pharmaceutical distributors in the United States, holds an Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical...
This is a federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, by the Defense Logistics Agency (DLA) Troop Support Medical. The $2,635.26 firm-fixed-price delivery order contract is for the supply of HUMALOG 100 UNIT/ML KWIKPEN 3ML, a prescription insulin product. The contract has an ultimate completion date of August 5, 2024. Amerisourcebergen holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up to...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corporation, a subsidiary of AmerisourceBergen Corporation. The contract, valued at $1,358.41, is for the delivery of HUMALOG 100 UNIT/ML KWIKPEN 3ML, a type of insulin medication. The contract has an ultimate completion date of May 14, 2024 and uses a firm fixed price pricing structure. This order is part of a larger Indefinite Delivery Contract (IDC) valued up to $999,999,999.00 that...
This federal contract award, valued at $1,604.86, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of HUMALOG 100 UNIT/ML KWIKPEN 3ML, a type of insulin medication. The contract is a Delivery Order with a Firm Fixed Price pricing type and has an ultimate completion date of July 28, 2023. This contract award is not designated as a set-aside. AmerisourceBergen...
This is a $1,024.32 delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The contract is for the delivery of Humalog 100 Unit/mL KwikPen 3mL, a brand-name insulin medication. The contract has an ultimate completion date of July 19, 2024 and is a firm fixed-price contract. The award was made on July 18, 2024 and there is no set-aside designation, indicating open competition. Amerisourcebergen holds a significant...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp's Corporate Office Division, a subsidiary of Amerisourcebergen Corporation. The contract is for the supply of HUMALOG 100 UNIT/ML KWIKPEN 3ML, a type of insulin medication. The contract is a Firm Fixed Price (FFP) agreement with a ceiling value of $1,115.40 and an ultimate completion date of May 2, 2024. Amerisourcebergen Drug Corp is a major supplier of pharmaceutical products and...
This is a $3,983.76 delivery order contract awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, by the Defense Logistics Agency (DLA) Troop Support Medical. The contract is for the supply of HUMALOG 100 UNIT/ML KWIKPEN 3ML, a prescription insulin product. The contract has a firm-fixed price and is for delivery of the product through September 23, 2024. This award is part of Amerisourcebergen's broader federal contracting activities, which include several Indefinite...
This is a delivery order contract awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, by the Defense Logistics Agency (DLA) Troop Support Medical. The contract is for the delivery of HUMALOG 100 UNIT/ML KWIKPEN 3ML, a prescription insulin medication, with a ceiling value of $1,024.32 and a completion date of November 14, 2024. The contract is not designated as a set-aside and was awarded on a firm fixed-price basis. Amerisourcebergen Drug Corp is a for-profit...
The U.S. Defense Logistics Agency (DLA) Troop Support Medical awarded a firm fixed price delivery order to AmerisourceBergen Drug Corp, the prime contractor, for the provision of HUMALOG 100 UNIT/ML KWIKPEN 3ML pharmaceutical products. The award has a potential value of $1,024.32 and a completion date of February 29, 2024. This delivery order is part of a larger indefinite delivery contract (IDC) awarded solely to AmerisourceBergen Drug Corp, which has a potential value of $999,999,999.00 and...
This is a firm fixed price delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of the global pharmaceutical distribution company Amerisourcebergen Corporation. The $1,024.32 order is for the supply of HUMALOG 100 UNIT/ML KWIKPEN 3ML, a branded insulin product. This order is part of a larger indefinite delivery contract (IDC) awarded solely to Amerisourcebergen Drug Corp, with a potential value up to $999,999,999.00 and a performance period...
  • SPE2DB22D1202
    Indefinite Delivery Contract
  • SPE2DB22D1202-SPE2DB25FUPZ5
    Delivery Order

This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $3,957.44 firm fixed-price contract is for the provision of HUMALOG 100 UNIT/ML KWIKPEN 3ML, a prescription insulin product. The contract has an ultimate completion date of January 21, 2025. AmerisourceBergen holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026, which serves as the primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. This delivery order is not designated as a set-aside contract. The DLA is the primary funding agency for this award, reflecting its role in supplying medical commodities to the U.S. Department of Defense and other federal healthcare programs.

Generated 4/18/25, 2:02 PM